Frazier Life Sciences Management, L.P. Valneva Se Put Options Transaction History
Frazier Life Sciences Management, L.P.
- $1.9 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VALN
# of Institutions
16Shares Held
663KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$3.33 Million0.14% of portfolio
-
Wells Fargo & Company San Francisco, CA245KShares$2.3 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il27.2KShares$255,8580.0% of portfolio
-
Ironwood Investment Management LLC Boston, MA25.1KShares$236,2690.07% of portfolio
-
Morgan Stanley New York, NY5.2KShares$48,9170.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $650M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...